Tango Therapeutics, Inc.

NASDAQ:TNGX

3.1 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -29.167-25.551-37.914-30.763-22.263-20.71-28.008-29.06-29.05-24.858-25.208-22.046-19.59-4.493-12.106-8.864-26.802-8.392-7.914
Depreciation & Amortization 0.6220.6320.6250.6170.6130.6040.5810.570.4170.3120.3090.2560.2250.2120.2040.1910.1860.1770.164
Deferred Income Tax 000-2.3640.739-1.7690000000000000
Stock Based Compensation 7.1787.5386.7194.8794.865.1214.2193.7853.8153.4253.2052.2573.431.1960.950.5310.4180.4070.408
Change In Working Capital 12.821-5.99-6.831-0.75-16.017-9.512-11.687-3.9784.623-10.752-8.3862.227-5.868-4.743-2.961-10.2461.7651.39-1.372
Accounts Receivables 000000200006-0.00600-2000
Change In Inventory 00000000000-0.422-5.19300-1.361000
Change In Accounts Payables 3.047-2.7661.042-0.088-1.957-1.2121.552-1.044.493-1.997-0.3590.365-1.8820.1922.5570.257000
Other Working Capital 9.774-3.224-7.873-0.662-14.06-8.3-15.239-2.9380.13-8.755-8.027-3.7161.213-4.935-5.518-7.1421.7651.39-1.372
Other Non Cash Items -24.84411.3326.4710.9140.9331.793-0.0120.4170.5840.3350.4150.4040.3090.310.30.326135.692-4.577-3.414
Operating Cash Flow -33.39-23.607-37.857-27.467-31.135-24.473-34.907-28.266-19.611-31.538-29.665-16.902-21.494-7.518-13.613-18.062111.259-10.995-12.128
Investing Activities:
Investments In Property Plant And Equipment -0.115-0.32-0.195-0.226-0.016-0.664-0.62-1.041-3.279-1.811-1.561-0.696-0.774-0.202-0.165-0.456-0.132-0.49-0.028
Acquisitions Net 000-34.07856.648-33.351-32.17111.564-18.507-37.30400.0320-0.0330166.71000
Purchases Of Investments -39.465-48.611-120.263-51.025-156.238-50.777-52.534-93.557-44.455-15.921-54.571-104.385-181.859-66.249-19.868-105.597000
Sales Maturities Of Investments 72.1561.63109.25585.10399.5984.12884.70581.99362.96253.22544.41559.87430.41959.82640.64546.883000
Other Investing Activites 013.019-11.00834.078-56.64833.35132.171-11.56418.50737.304-10.156-0.032-00.03320.777-166.75-69.617-27.90611.917
Investing Cash Flow 32.5712.699-11.20333.852-56.66432.68731.551-12.60515.22835.493-11.717-45.207-152.214-6.62520.612-59.21-69.749-28.39611.889
Financing Activities:
Debt Repayment 0000000000000000000
Common Stock Issued -44.2931.31141.7230.84179.8390.5860.0731.6230.1130.7180.2650.0290.0010.02500.025000
Common Stock Repurchased 0000000000000000000
Dividends Paid 0000000000000000000
Other Financing Activities 2.4021.3111.2591.4670.4410.5860.0730.5270.1130.7180.257-0.12327.78-0.75430.411-0.15151.08629.8590
Financing Cash Flow 2.4021.31142.9821.46780.280.5860.0730.5270.1130.7180.257-0.12327.78-0.74630.411-0.06151.08629.8590
Other Information:
Effect Of Forex Changes On Cash 0007.6490-7.64900000-0.786-155.17914.213-37.46677.095000
Net Change In Cash 1.582-9.597-6.0787.852-7.5198.8-3.283-40.344-4.274.673-41.125-62.229154.072-14.88937.41-77.33392.596-9.532-0.239
Cash At End Of Period 55.71551.56661.16369.80861.95669.47560.67563.958104.302108.572103.899145.024207.25353.18168.0730.66107.99315.39724.929